DYNAL™ MyOne™ Dynabeads™ Streptavidin C1

Exceptional standard for isolation and handling of biotinylated nucleic acids, antibodies, or other biotinylated ligands and targets

Overview
Brand: Invitrogen

Manufacturer Part Number: 65002

10 ML DYNABEADS MYONE STREPTAVIDIN C1 DYNAL(R)Invitrogen SKU 65002 10mL

UNSPSC: 41116133

Code: 50

Additional Details:
Additional Details: Weight: 0.04200kg



Product Code. 10202333

Quantity Price
1 £ 1128.0 / Each
EU Stock 12
Add to basket

For Research Use Only. All usage must comply with product instructions.
 

Description and Specification

Specification

Concentration 10mg/mL
For Use With (Application) High-throughput
Quantity 10mL

Uniform and superparamagnetic beads are 1μm in diameter with a monolayer, not a multilayer, of recombinant streptavidin covalently coupled to the surface. This leaves the vast majority of the biotin binding sites sterically available for binding, not only of free biotin, but also for binding of biotinylated ligands/targets. They are hydrophilic, negatively charged, and show rapid liquid-phase reaction kinetics. Their specific and defined surface allow for efficient capture, separation, and downstream handling. The streptavidin monolayer ensures negligible leakage, and the lack of excess adsorbed streptavidin ensures batch consistency and reproducibility of results. The 1μm Dynabead MyOne have a large surface area, high capacity, efficient magnetic pull and a slow sedimentation rate during incubation. Tailor-made for use in automated protocols where high throughput is crucial. The product holds high standards with respect to reproducibility (both within and between batches), and automation ability, and drives reliability of results.

  • ery high binding affinity of the streptavidin-biotin interaction (Kd=10-15) is used in a vast number of applications
  • Direct and fast isolation of any biotinylated molecule
  • Flexible protocols with gentle and efficient liquid-phase reaction kinetics
  • Well suited for nucleic acid applications with extreme demands
  • Very low nonspecific binding of nucleotides and nucleic acids
  • Low nonspecific binding of small and negatively charged proteins
  • Their small but uniform size presents a high surface area per mg beads and a correspondingly high capacity for the target molecule
  • Low sedimention rate, yet a high iron content, ensuring rapid magnetic separation
  • Biomagnetic protocols are easily adapted to automated platforms
  • High batch-to-batch reproducibility, securing consistent results in your application
  • Production follows a validated process in compliance with cGMP for medical devices

DNA and RNA Purification and Analysis, DNA Extraction, Immunoprecipitation, Protein and Peptide Purification, Protein Sample Preparation and Protein Purification, Proteins, Expression, Isolation and Analysis, RNAi, Epigenetics and Noncoding RNA Research, Sequence-Specific DNA or RNA Purification, Viral RNA/DNA Purification